Xiaoyan Qiu
- Immunology top 5%
- Immunotherapy and Immune Responses 6
- Immune Cell Function and Interaction 5
- Immunodeficiency and Autoimmune Disorders 3
-
- Monoclonal and Polyclonal Antibodies Research 15
- Oncology top 10%
- Cancer-related Molecular Pathways 4
-
- Glycosylation and Glycoproteins Research 15
- Ubiquitin and proteasome pathways 4
-
- Chronic Lymphocytic Leukemia Research 6
- Co-authors
- Youhui ZhangJing HuangXiaohui ZhuYuntao S. MaoLiang ZhangGuohui LiC. Cameron YinFanlei Hu
- Journals
- Journal of Biological Chemistry (1 paper)Biochemical and Biophysical Research Communications (1 paper)International Journal of Molecular Sciences (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xiaoyan Qiu
33 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 94
- Immunology 525
- Radiology, Nuclear Medicine and Imaging 335
- Oncology 234
- Molecular Biology 551
- Cancer Research 108
Countries citing papers authored by Xiaoyan Qiu
This map shows the geographic impact of Xiaoyan Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyan Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyan Qiu more than expected).
Fields of papers citing papers by Xiaoyan Qiu
This network shows the impact of papers produced by Xiaoyan Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyan Qiu. The network helps show where Xiaoyan Qiu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaoyan Qiu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2021 | 8 | |
| 5 | 2021 | 57 | |
| 6 | 2021 | 4 | |
| 7 | 2019 | 43 | |
| 8 | 2019 | 24 | |
| 9 | 2018 | 9 | |
| 10 | 2017 | 12 | |
| 11 | 2017 | 13 | |
| 12 | 2016 | 4 | |
| 13 | 2012 | 21 | |
| 14 | 2010 | 36 | |
| 15 | 2009 | 72 | |
| 16 | 2008 | 22 | |
| 17 | 2008 | 55 | |
| 18 | 2008 | 27 | |
| 19 | 2005 | 40 | |
| 20 | 2003 | 14 |
About Xiaoyan Qiu
Xiaoyan Qiu is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 37 papers that have together received 1.1k indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (15 papers), Monoclonal and Polyclonal Antibodies Research (15 papers), Chronic Lymphocytic Leukemia Research (6 papers), Immunotherapy and Immune Responses (6 papers), Immune Cell Function and Interaction (5 papers), Ubiquitin and proteasome pathways (4 papers), Cancer-related Molecular Pathways (4 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). The work is most often cited by research in Immunology (525 citations), Radiology, Nuclear Medicine and Imaging (335 citations) and Oncology (234 citations). Xiaoyan Qiu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Youhui Zhang, Jing Huang, Xiaohui Zhu, Yuntao S. Mao, Liang Zhang, Guohui Li, C. Cameron Yin, Fanlei Hu, Qinyuan Liao and Xin Sun. Their work appears in journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.